Galectin‐3 and ST2 as predictors of therapeutic success in high‐risk patients undergoing percutaneous mitral valve repair (MitraClip)

BACKGROUND: Percutaneous mitral valve repair (PMVR) is an interventional treatment option in patients with severe mitral regurgitation (MR) and at high risk for open‐heart surgery. Currently, limited information exists about predictors of procedural success after PMVR. Galectin‐3 (Gal‐3) and suppres...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cardiol
Autors principals: Dörr, Oliver, Walther, Claudia, Liebetrau, Christoph, Keller, Till, Sommer, Thomas, Boeder, Niklas, Bayer, Matthias, Bauer, Pascal, Möllmann, Helge, Gaede, Luise, Troidl, Christian, Voss, Sandra, Bauer, Timm, Hamm, Christian W., Nef, Holger
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2018
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489771/
https://ncbi.nlm.nih.gov/pubmed/29896861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22996
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars